Skip to main content
logo
Defence Therapeutics Inc. (CSE:DTC)
Canada flag Canada · Delayed Price · Currency is CAD
0.3500
0.00 (0.00%)
Oct 30, 2026, 3:57 PM EDT

Defence Therapeutics Ratios and Metrics

Millions CAD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
2733383412873
Market Cap Growth
-39.41%-12.95%13.68%-73.58%74.18%-70.15%
Enterprise Value
2632383512672
Last Close Price
0.350.440.700.742.922.00

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PB Ratio
7.569.50-30.50-9.4081.44-188.95
P/TBV Ratio
7.569.50--83.51-

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Debt / Equity Ratio
0.490.49-1.20-0.491.12-
Net Debt / Equity Ratio
-0.05-0.05-0.22-0.47-0.671.31
Net Debt / EBITDA Ratio
0.030.03-0.09-0.130.16-
Net Debt / FCF Ratio
0.030.03-0.08-0.380.140.08
Quick Ratio
3.373.370.490.0413.350.48
Current Ratio
3.423.420.500.0515.580.61
Return on Equity (ROE)
-594.03%-594.03%---1147.59%-288.03%
Return on Assets (ROA)
-75.53%-75.53%-187.25%-397.30%-190.91%-143.66%
Return on Capital Employed (ROCE)
-94.30%-94.30%254.00%356.40%-196.10%1876.80%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-31.43%-20.08%-9.19%-39.15%-5.30%-10.03%
FCF Yield
-17.95%-14.28%-8.88%-13.33%-6.05%-8.25%
Buyback Yield / Dilution
-24.78%-24.78%-11.64%-12.54%-9.93%-35.65%